Phase II trial of docetaxel and carboplatin in patients with advanced squamous carcinoma of the esophagus (E2298): A trial of the eastern cooperative oncology group

Gastrointestinal Cancer Research

Volumn 4, Issue 1, 2011, Pages 9-14

  Rossman, Joanne F ^a   Falkson, Carla I ^a   Xu, Ronghui ^b   Slabber, Coenraad F ^c   Mason, Bernard A ^d   Mulcahy, Mary F ^e   Benson III, Al B ^e  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^b DANA FARBER CANCER INSTITUTE   (United States)

^c UNIVERSITY OF PRETORIA   (South Africa)

^d PENNSYLVANIA HOSPITAL   (United States)

^e NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARBOPLATIN; DEXAMETHASONE; DOCETAXEL;

ADULT; ADVANCED CANCER; AGED; ANEMIA; ANOREXIA; ARTICLE; CANCER GROWTH; CAUCASIAN; CAUSE OF DEATH; CLINICAL ARTICLE; DEHYDRATION; DIARRHEA; DRUG EFFICACY; DRUG INFUSION; DRUG RESPONSE; DYSPHAGIA; DYSPNEA; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; ESOPHAGUS FISTULA; FATIGUE; FEBRILE NEUTROPENIA; FEMALE; GASTRITIS; HUMAN; HYPOKALEMIA; HYPOMAGNESEMIA; HYPONATREMIA; HYPOPHOSPHATEMIA; HYPOTENSION; INFECTION; INTESTINE OBSTRUCTION; LEUKOPENIA; LUNG INFILTRATE; MALE; MOTOR NEUROPATHY; MULTICENTER STUDY; MULTIPLE CYCLE TREATMENT; NEGRO; NEUTROPENIA; OUTCOME ASSESSMENT; PHASE 2 CLINICAL TRIAL; PNEUMONIA; REPEATED DRUG DOSE; SIDE EFFECT; THROMBOCYTOPENIA; VOMITING;

EID: 79955598521     PISSN: 19347820     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Sitas F, Terblanche M: Incidence and geographical distribution of histologically diagnosed cancer in South Africa, 1990 & 1991, in National Cancer Registry of South Africa, 1996
2. Parker S, Tong T, Bolden S, et al: Cancer statistics. CA Cancer J Clin 46:5, 1996
3. Jemal A, Siegel R, Ward E: Cancer statistics. CA Cancer J Clin 58:71-96, 2008
4. Iizuka T, Kakegawa T, Ide H: Phase II evaluation of cisplatin and 5-fluorouracil in advanced squamous cell carcinoma of the esophagus: a Japanese Esophageal Oncology Group trial. Jpn J Clin Oncol 22:172-176, 1992
5. Polee M, Kok T, Siersema P, et al: Phase II study of the combination cisplatin, etoposide, 5-fluorouracil and folinic acid in patients with advanced squamous cell carcinoma of the esophagus. Anticancer Drugs 12:513-517, 2001
6. Ilson D, Ajani J, Bhalla K: Phase II trial of paclitaxel, fluorouracil, and cisplatin in patients with advanced carcinoma of the esophagus. J Clin Oncol 16:1826-1834, 1998
7. Engstrom P, Lavin P, Klaassen D: Phase II evaluation of mitomycin and cisplatin in advanced esophageal carcinoma. Cancer Treat Rep 67: 713-715, 1983
8. Davis S, Shanmugathasa M, Kessler W: Cisdichlorodiammineplatinum (II) in the treatment of esophageal carcinoma. Cancer Treat Rep 64: 709-711, 1980
9. Pannettiere F, Leichman L, Tilchen E: Chemotherapy for advanced epidermoid carcinoma of the esophagus with single agent cisplatin: final report on a Southwest Oncology Group Study. Cancer Treat Rep 68:1023-1024, 1984
10. Ravry M, Moore M, Omura G: Phase II evaluation of cisplatin in squamous carcinoma of the esophagus: a Southeastern Cancer Study Group trial. Cancer Treat Rep 69:1457-1458, 1985
11. Advani S, Saikia T, Swaroop S: Anterior chemotherapy in esophageal cancer. Cancer 56:1502-1506, 1985
12. Falkson G: Methyl-GAG (NSC-32946) in the treatment of esophagus cancer. Cancer Chemother Rep 55:209-212, 1971
13. Kelsen D, Chapman R, Bains M: Phase II study of methyl-GAG in the treatment of esophageal carcinoma. Cancer Treat Rep 66:1427-1429, 1982
14. Coia L: The use of mitomycin in esophageal cancer. Oncology 50:53-60, 1993
15. Ajani J, IIlson D, Daugherty K, et al: Activity of taxol in patients with squamous cell carcinoma and adenocarcinoma of the esophagus. J Natl Cancer Inst 86:1086-1091, 1994
16. Sternberg C, Kelsen D, Dukeman M: Carboplatin: a new platinum analog in the treatment of epidermoid carcinoma of the esophagus. Cancer Treat Rep 69:1305-1307, 1985
17. Mannell A, Winters Z: Carboplatin in the treatment of esophageal cancer. S Afr Med J 76: 213-214, 1989
18. Slabber CF, Falkson CI, Musi NNM, et al: A phase II study of docetaxel in advanced, inoperable squamous carcinoma of the esophagus. Proc Am Soc Clin Oncol 18:, 1999 (abstr 1151)
19. Ajani J: Contribution of chemotherapy in the treatment of carcinoma of the esophagus: results and commentary. Semin Oncol 21:474-482, 1994
20. Ilson D, Saltz L, Enzinger P: Phase II trial of weekly irinotecan plus cisplatin in advanced esophageal cancer. J Clin Oncol 17:3270-3275, 1999
21. El-Rayes B, Shields A, Zalupski M: A phase II study of carboplatin and paclitaxel in esophageal cancer. Ann Oncol 15:960-965, 2004
22. Zhang X, Shen L, Li J, et al: A phase II trial of paclitaxel and cisplatin in patients with advanced squamous cell carcinoma of the esophagus. Am J Clin Oncol 31:29-33, 2008